The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations, except those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Click “OK” to confirm you are a Healthcare Professional.
Learn more about clinical evidence for the Endurant™ II-IIs AAA stent graft system.
The Endurant™ family of products have been chosen by physicians to treat more than half a million patients worldwide.1
As the first and only endovascular aneurysm repair (EVAR) system with a decade of global registry outcomes, Endurant™ systems continue to prove durability and strength in evidence with consistently high sac regression and low aneurysm-related mortality (ARM).2
ꝉ Delivery success = successful vascular access and delivery of the device to the intended anatomical treatment site. Deployment success = successful deployment of the device in the intended site and the successful removal of the delivery system.
‡ Data reported through ten-year time frame with full +extended cohort, determined by Clinical Event Committee.
§ Data reported through ten-year time frame with full +extended cohort.
◊ Aneurysm-related re-interventions are defined as all the secondary endovascular procedures (scheduled and unscheduled), secondary vascular procedures and conversions to open repair.
¶ Data reported at ten-year time frame with extended cohort.
# Data reported through five-year time frame determined by Clinical Event Committee.
∆ Data reported at five-year time frame.
∞ Numbers are freedom from (FF) event survival estimate % based on Kaplan-Meier method.
ꝉꝉ Numbers are freedom from (FF) event survival estimate % based on interval-censored method.
‡‡ (p < 0.05).
Based on internal Endurant™ patient implant tracking at Medtronic. Data current as of September 2023.
Verhagen et al. The ENGAGE Registry: Ten-Year Outcomes with the Endurant Stent Graft for Endovascular Abdominal Aortic Aneurysm Repair. Presented at: Charing Cross 2023 International Symposium; April 26, 2023; London, UK.
Rouwet EV, Torsello G, de Vries JP, et al. Final results of the prospective European trial of the Endurant stent graft for endovascular abdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg. 2011 Oct;42(4):489–497.
Singh MJ, Fairman R, Anain P, et al. Final Results of the Endurant Stent Graft System in the United States Regulatory Trial. J Vasc Surg. 2016;64:55–62.
Teijink JAW, Power AH, Böckler D, et al. Editor's Choice - Five Year Outcomes of the Endurant Stent Graft for Endovascular Abdominal Aortic Aneurysm Repair in the ENGAGE Registry. Eur J Vasc Endovasc Surg. August 2019;58(2):175–181.
Based on internal 5Y short neck cohort data report conducted 2017.
Makaroun MS, Tuchek M, Massop D, et al. One year outcomes of the United States regulatory trial of the Endurant Stent Graft System. J Vasc Surg. September 2011;54(3):601–608.
You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
We do not review or control the content on non-Medtronic sites, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in your region or country.
